This grant supports clinical trials and research to improve pain management, addiction treatment, anesthesia safety, and drug prescribing practices.
NIH supports milestone-driven development of non-addictive small molecule and biologic pain treatments, from lead optimization through Phase I testing, to prepare candidates for Phase II trials.
Funding for research developing non-addictive pain treatments through early drug discovery to support the Pain Therapeutics Development Program.
This grant funds research to speed up the use of proven addiction prevention, treatment, and recovery methods for opioid and overdose crises, focusing on scalable, evidence-based solutions at multiple levels.
CDC funds research to develop, implement, and evaluate strategies that improve linkage to care in health care settings for people with opioid use disorder at risk of overdose.
NIH supports exploratory, phased clinical research on the neurobiological mechanisms of substance use disorders, including relevant circuitry and behavior; clinical trials are optional.